Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8595
Reference
Drug Alert 52/2025
Name
Drug Alert class 4 – No 52 2025 – Class 4 medicines defect information – caution in use – Flamingo Pharma UK Ltd – Amitriptyline Hydrochloride 10mg, 25mg and 50mg tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Industry
Medicines Recall
Description
Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. The errors were identified following an MHRA Good Pharmacovigilance Practice (GPvP) inspection and further investigation by the Marketing Authorisation Holder, Flamingo Pharma UK Ltd.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2025-12-10 10:21:00
Click to go back to homepage